Stifel initiates coverage on CRNX, a clinical-stage pharmaceutical company focused on endocrine diseases and tumors.

Patients with congenital adrenal hyperplasia (CAH) receiving glucocorticoid therapy showed reduced bone mineral density (BMD), with young adult male patients particularly affected and experiencing ...

Kaken Pharmaceutical will hand Alumis $40 million in the near term for the rights to develop a late-stage tyrosine kinase 2 ...

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) had its price target increased by equities researchers at JPMorgan Chase & ...

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) shot up 8.9% during trading on Monday after JPMorgan Chase & Co. raised their price target on the stock from $44.00 to $50.00. JPMorgan ...

The non-profit Hearts For Isabella was in the lead on efforts to raise more than $11,000 for a Belfast man, born with a rare ...

Kausel noted that while a little chin hair here and there in older women is normal, it should be minimal. If you notice a lot ...

Approximately one in every 100 babies born in the United States has congenital heart disease, often requiring cardiac surgery ...

PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly ...

My message to everyone is simple—take the first step, seek professional advice, and remember, "The best investment you can ...

One local family is raising money to give their daughter Kaylin Nichols an adaptive bike. Here's how the community is helping ...

In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...